Across TCGA pan-cancer cohorts, GXYLT1P7 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of GXYLT1P7’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where GXYLT1P7 RNA is repressed in tumor relative to normal tissue. In most cancer types GXYLT1P7 is over-expressed in tumor, although a few such as STAD and BRCA show the opposite, repressed pattern.

STAD, BRCA, and LUAD are the cancer types where GXYLT1P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GXYLT1P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	−0.034	.015	4	view →
BRCA	All	All	−0.030	.006	4	view →
LUAD	All	All	+0.030	.008	3	view →
KIRC	All	All	−0.023	.009	2	view →
KICH	Male	All	−0.051	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: GXYLT1P7 RNA expression & survival · all GXYLT1P7 data types